Cause of death, by non-communicable diseases, ages 0-4, male in Syria
Syria: Cause of death, by non-communicable diseases, ages 0-4, male was 33.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, male in Syria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, male in Syria stood at 33.1%.
Compared with earlier readings it is down 1.2% on the previous year and down 6.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Syria peaked at 35.3% in 2010 and was at its lowest, 21.0%, in 2015.
That places Syria 82nd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 0-4, male in Syria, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 29.7% | — |
| 2010 | 35.3% | +18.8% |
| 2015 | 21.0% | -40.5% |
| 2019 | 34.9% | +66.2% |
| 2020 | 33.5% | -3.8% |
| 2021 | 33.1% | -1.2% |
Syria compared with similar countries
- Syria's 33.1% is above the median for low income countries, which is 6.5%, 5.1× the median. (25 countries reporting)
- Syria's 33.1% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 35.4%, 94% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 29.7% | 29.7% | 29.7% | 1 |
| 2010s | 30.4% | 21.0% | 35.3% | 3 |
| 2020s | 33.3% | 33.1% | 33.5% | 2 |
Countries ranked near Syria
More health data for Syria
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Syria?
- Cause of death, by non-communicable diseases, ages 0-4, male in Syria was 33.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Syria?
- The highest recorded value was 35.3% in 2010.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Syria?
- The lowest recorded value was 21.0% in 2015.
- How does Syria rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Syria ranks 82nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Syria?
- Over the last ten years it is down 6.0%. The long-run trend across the full record is rising.
- Where does this Syria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.